Back to Search
GAGAN DEEP, DMD
DMD
General Practice Dentistry
NPI: 1407521420Individual
Specialties, Licenses & Credentials
General Practice DentistryPrimary
Dentist — General Practice
Code: 1223G0001X
DS043317(PA)108686(CA)
Research & Publications (18)
Isosilibinin inhibits advanced human prostate cancer growth in athymic nude mice: comparison with silymarin and silibinin.
PMID 18798272·Int J Cancer·2008
4-observational
New combination therapies with cell-cycle agents.
PMID 18516759·Curr Opin Investig Drugs·2008
6-review
Identifying the differential effects of silymarin constituents on cell growth and cell cycle regulatory molecules in human prostate cancer cells.
PMID 18435416·Int J Cancer·2008
4-observational
Isosilybin B causes androgen receptor degradation in human prostate carcinoma cells via PI3K-Akt-Mdm2-mediated pathway.
PMID 18332867·Oncogene·2008
8-other
Chemopreventive efficacy of silymarin in skin and prostate cancer.
PMID 17548792·Integr Cancer Ther·2007
6-review
Isosilybin B and isosilybin A inhibit growth, induce G1 arrest and cause apoptosis in human prostate cancer LNCaP and 22Rv1 cells.
PMID 17389612·Carcinogenesis·2007
8-other
Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.
PMID 16205633·Oncogene·2006
8-other
Silibinin suppresses growth and induces apoptotic death of human colorectal carcinoma LoVo cells in culture and tumor xenograft.
PMID 19638451·Mol Cancer Ther·2009
7-preclinical
Silibinin suppresses growth of human prostate carcinoma PC-3 orthotopic xenograft via activation of extracellular signal-regulated kinase 1/2 and inhibition of signal transducers and activators of transcription signaling.
PMID 19147767·Clin Cancer Res·2009
7-preclinical
Kava, a tonic for relieving the irrational development of natural preventive agents.
PMID 19138987·Cancer Prev Res (Phila)·2008
7-preclinical
Stage-specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model.
PMID 18701508·Cancer Res·2008
7-preclinical
Silibinin inhibits cytokine-induced signaling cascades and down-regulates inducible nitric oxide synthase in human lung carcinoma A549 cells.
PMID 18644994·Mol Cancer Ther·2008
8-other
Chemopreventive effects of oral gallic acid feeding on tumor growth and progression in TRAMP mice.
PMID 18445658·Mol Cancer Ther·2008
7-preclinical
Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model.
PMID 18006855·Cancer Res·2007
7-preclinical
Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft.
PMID 17916909·Carcinogenesis·2007
7-preclinical
Effect of silibinin on the growth and progression of primary lung tumors in mice.
PMID 16788158·J Natl Cancer Inst·2006
7-preclinical
Chemopreventive potential of Triphala (a composite Indian drug) on benzo(a)pyrene induced forestomach tumorigenesis in murine tumor model system.
PMID 16471318·J Exp Clin Cancer Res·2005
7-preclinical
Cancer preventive potential of Momordica charantia L. against benzo(a)pyrene induced fore-stomach tumourigenesis in murine model system.
PMID 15233304·Indian J Exp Biol·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1919 SUSQUEHANNA RD
ABINGTON, PA 19001 - Phone
- (909) 802-6159
Quick Facts
- NPI
- 1407521420
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 18
Are you this provider?
Claim Your Profile